Remove Advocacy Remove Cannabinoids Remove Consumption Remove Patients
article thumbnail

Medical Cannabis Advisory Board votes to add two qualifying conditions

Illinois News Joint

MCAB board members took preliminary votes to include two qualifying debilitating conditions for medical cannabis patients in Illinois. Mulvehill introduced Illinois resident Gabriella Bova, who also advocated for including FOD as debilitating condition for medical patients. I dealt with the sexual shame and stigma of having FOD.

article thumbnail

Move over CBD—CBN is Canada’s new trending cannabinoid

SpeedWeed

Meet Canada’s newest favourite cannabinoid—CBN. Regardless, a new flood of cannabinoid-specific products have hit the Canadian market. Regardless, a new flood of cannabinoid-specific products have hit the Canadian market. Consumers are seeking out new cannabinoids. But what is driving this trend? How is it made?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Economic Impact of the Medical Marijuana Industry: Trends and Projections

MMJ Recs

Recent trends indicate a growing interest in alternative forms of consumption, such as edibles, topicals, and concentrates, in addition to traditional flower products. Key factors influencing market size and revenue include patient demographics, regulatory frameworks, product offerings, and pricing strategies.

article thumbnail

Why Are States Moving to Ban Delta 8 THC Products?

Veriheal

Many states across the United States have chosen to legalize cannabis for either medical or both medical and retail consumption. However, in most cases, this involves the strength of products and the content of various cannabinoids such as CBD and THC. What is Delta 8 THC?

THC 104
article thumbnail

Vermont’s Cannabis Board Rejects Proposed 15% THC Cap on Cannabis

Veriheal

The state’s leading physician advocacy group, the Vermont Medical Society , initially issued the rejected recommendations to the Cannabis Control Board. Interestingly, medical cannabis products in Vermont are not restricted based on their level of cannabinoid potency. However, many of these myths have already been dispelled.

THC 96
article thumbnail

Medicinal cannabis users in the UK could be unfairly criminalised as study finds failures in roadside drug testing

Cannabis Law Report

The results show that driving impairment for a regular cannabis consumer, when compared to the controlled placebo receiving group, was highest at 30 mins post-consumption. hours after consumption. hours after consumption. Further simulator tests were given at 30 minutes, 1.5, hours after smoking. After about 3.5

article thumbnail

NORML Chapter Newsletter

NORML

“That’s why dozens of NORML chapters are organizing citizen lobby days to advocate for the end of marijuana prohibition and other reforms ranging from depenalization and expungement, to workplace drug testing and social consumption.”. Grower Advocacy Council and the Mass. Patient Advocacy Alliance to Host Second Annual Harvest Cup. “We

Advocacy 126